NPI: 1669583084 · HIALEAH, FL 33016 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 08/31/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 08/31/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 17,392 | $647K |
| 2019 | 35,407 | $2.05M |
| 2020 | 34,753 | $3.57M |
| 2021 | 31,505 | $1.11M |
| 2022 | 20,001 | $1.68M |
| 2023 | 10,448 | $452K |
| 2024 | 1,653 | $49K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 40,168 | 2,150 | $3.01M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 51,822 | 1,577 | $2.49M |
| J1270 | Injection, doxercalciferol, 1 mcg | 26,669 | 1,284 | $1.57M |
| A4657 | Syringe, with or without needle, each | 4,675 | 1,857 | $620K |
| J1756 | Injection, iron sucrose, 1 mg | 9,044 | 1,450 | $562K |
| 83970 | 3,112 | 1,338 | $241K | |
| 85048 | 3,368 | 1,552 | $212K | |
| 85041 | 2,900 | 1,549 | $209K | |
| 82728 | 1,950 | 1,068 | $141K | |
| 83540 | 1,947 | 1,061 | $119K | |
| 83550 | 1,881 | 1,019 | $118K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 837 | 496 | $74K |
| 82607 | 853 | 493 | $60K | |
| 82746 | 802 | 475 | $58K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 327 | 100 | $25K |
| 82108 | 232 | 132 | $20K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 273 | 133 | $20K |
| G0008 | Administration of influenza virus vaccine | 123 | 82 | $5K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 131 | 50 | $4K |
| 90662 | 45 | 25 | $798.00 |